# EEG Study of IV Methylphenidate-Induced Emergence From Propofol Sedation

> **NCT03610282** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** IV Methylphenidate
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03610282
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11
- **Primary completion:** 2020-11
- **Final completion:** 2021-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We have decided to withdraw the study prior to enrollment of the first participant in order to pursue other research studies.
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03610282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03610282, "EEG Study of IV Methylphenidate-Induced Emergence From Propofol Sedation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03610282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*